C113H139Cl5F3N35O4 — CID 158824373
5-chloro-2-N-[2-fluoro-5-methyl-4-(1-methylpiperidin-4-yl)phenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-(2-fluoro-5-methyl-4-piperidin-4-ylphenyl)-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-[5-methyl-4-(1-methylpiperidin-4-yl)-2-propan-2-yloxyphenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;(2S)-2-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-5-fluoro-2-methylphenyl]piperidin-1-yl]propanamide;ethyl 4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]methyl]-2,5-dimethylphenyl]piperidine-1-carboxylate (PubChem CID 158824373) has the molecular formula C113H139Cl5F3N35O4 and a molecular weight of 2285.85 g/mol. Its IUPAC name is 5-chloro-2-N-[2-fluoro-5-methyl-4-(1-methylpiperidin-4-yl)phenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-(2-fluoro-5-methyl-4-piperidin-4-ylphenyl)-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-[5-methyl-4-(1-methylpiperidin-4-yl)-2-propan-2-yloxyphenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;(2S)-2-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-5-fluoro-2-methylphenyl]piperidin-1-yl]propanamide;ethyl 4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]methyl]-2,5-dimethylphenyl]piperidine-1-carboxylate.
| Compound Name | 5-chloro-2-N-[2-fluoro-5-methyl-4-(1-methylpiperidin-4-yl)phenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-(2-fluoro-5-methyl-4-piperidin-4-ylphenyl)-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-[5-methyl-4-(1-methylpiperidin-4-yl)-2-propan-2-yloxyphenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;(2S)-2-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-5-fluoro-2-methylphenyl]piperidin-1-yl]propanamide;ethyl 4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]methyl]-2,5-dimethylphenyl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 158824373 |
| Molecular Formula | C113H139Cl5F3N35O4 |
| Molecular Weight | 2285.85 g/mol |
| Exact Mass | 2282.01 |
| IUPAC Name | 5-chloro-2-N-[2-fluoro-5-methyl-4-(1-methylpiperidin-4-yl)phenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-(2-fluoro-5-methyl-4-piperidin-4-ylphenyl)-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;5-chloro-2-N-[5-methyl-4-(1-methylpiperidin-4-yl)-2-propan-2-yloxyphenyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine;(2S)-2-[4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]-5-fluoro-2-methylphenyl]piperidin-1-yl]propanamide;ethyl 4-[4-[[5-chloro-4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]methyl]-2,5-dimethylphenyl]piperidine-1-carboxylate |
| SMILES | CCOC(=O)N1CCC(c2cc(C)c(Cc3ncc(Cl)c(Nc4cc(C)[nH]n4)n3)cc2C)CC1.Cc1cc(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3F)ncc2Cl)n[nH]1.Cc1cc(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC(C)C)ncc2Cl)n[nH]1.Cc1cc(Nc2nc(Nc3cc(C)c(C4CCN([C@@H](C)C(N)=O)CC4)cc3F)ncc2Cl)n[nH]1.Cc1cc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3F)ncc2Cl)n[nH]1 |
| InChI | InChI=1S/C25H31ClN6O2.C24H32ClN7O.C23H28ClFN8O.C21H25ClFN7.C20H23ClFN7/c1-5-34-25(33)32-8-6-18(7-9-32)20-11-15(2)19(10-16(20)3)13-22-27-14-21(26)24(28-22)29-23-12-17(4)30-31-23;1-14(2)33-21-12-18(17-6-8-32(5)9-7-17)15(3)10-20(21)27-24-26-13-19(25)23(29-24)28-22-11-16(4)30-31-22;1-12-8-19(18(25)10-16(12)15-4-6-33(7-5-15)14(3)21(26)34)28-23-27-11-17(24)22(30-23)29-20-9-13(2)31-32-20;1-12-8-18(17(23)10-15(12)14-4-6-30(3)7-5-14)25-21-24-11-16(22)20(27-21)26-19-9-13(2)28-29-19;1-11-7-17(16(22)9-14(11)13-3-5-23-6-4-13)25-20-24-10-15(21)19(27-20)26-18-8-12(2)28-29-18/h10-12,14,18H,5-9,13H2,1-4H3,(H2,27,28,29,30,31);10-14,17H,6-9H2,1-5H3,(H3,26,27,28,29,30,31);8-11,14-15H,4-7H2,1-3H3,(H2,26,34)(H3,27,28,29,30,31,32);8-11,14H,4-7H2,1-3H3,(H3,24,25,26,27,28,29);7-10,13,23H,3-6H2,1-2H3,(H3,24,25,26,27,28,29)/t;;14-;;/m..0../s1 |
| InChIKey | IWGSMNKEHOSOKX-GLAWKEQLSA-N |
| XLogP | 24.62 |
| TPSA | 484.18 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 160 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2285.85 |
| LogP ≤ 5 | 24.62 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 32 |